You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT JAMA
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 299 No. 21, June 4, 2008 TABLE OF CONTENTS
  JAMA
  •  Online Features
  Letters
 This Article
 •Full text
 •PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Contact me when this article is cited
 Related Content
 •Related article
 •Related letter
 •Similar articles in JAMA
 Topic Collections
 •Drug Therapy, Other
 •Radiation Therapy
 •Alert me on articles by topic

Radiopharmaceutical Reimbursement Rates—Reply

Since this article does not have an abstract, we have provided the first 60 words of the full text and any section headings.

In Reply: I appreciate Dr Singer's comments and agree that changes in Congress have occurred between the time that the news article was written and the time that it appeared in print. Congress has temporarily put a stop to cuts on radiotherapy reimbursements. It is unclear whether additional extensions or other actions will occur this summer.

Financial Disclosures: None reported.

Tracy Hampton, PhD
tracy.hampton@jama-archives.org
JAMA
Chicago, Illinois

Letters Section Editor: Robert M. Golub, MD, Senior Editor.

JAMA. 2008;299(21):2512-2513.


RELATED ARTICLE

Phase 3 Trials Suggest Ways to Improve Current Hematologic Cancer Therapies
Tracy Hampton
JAMA. 2008;299(5):510-512.
EXTRACT | FULL TEXT  

RELATED LETTER

Radiopharmaceutical Reimbursement Rates
Jack W. Singer
JAMA. 2008;299(21):2512.
EXTRACT | FULL TEXT  






HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2008 American Medical Association. All Rights Reserved.